ProCE Banner Activity

Cutting-Edge Concepts in HIV Care―Pharmacist Perspectives

Clinical Thought
We now have long-acting injectable options for both the treatment and prevention of HIV, with more to learn as we incorporate this exciting new paradigm. Here are my thoughts on key differences among available HIV prevention medications and the potential role of individual pharmacokinetic variability in the efficacy of long-acting options for prevention and treatment.

Released: December 30, 2022

Expiration: December 29, 2023

No longer available for credit.

Share

Faculty

Melanie Nicol

Melanie Nicol, PharmD, PhD

Associate Professor
Department of Experimental and Clinical Pharmacology
College of Pharmacy
University of Minnesota
Minneapolis, Minnesota

Provided by

Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC
ProCE Banner

Supporters

ViiV Healthcare

Faculty Disclosure

Primary Author

Melanie Nicol, PharmD, PhD

Associate Professor
Department of Experimental and Clinical Pharmacology
College of Pharmacy
University of Minnesota
Minneapolis, Minnesota

Melanie Nicol, PharmD, PhD, has no relevant financial relationships to disclose.